Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person Jassal, Bijay, 2020-04-22
| Class:Id | InstanceEdit:9684954 |
| _displayName | Jassal, Bijay, 2020-04-22 |
| _timestamp | 2020-04-22 10:11:37 |
| author | [Person:73447] Jassal, Bijay |
| dateTime | 2020-04-22 10:10:59 |
| (created) | [Person:9684950] Peterson, Danielle [Person:9684951] Chun, Jerold [Person:9684952] Hartung, Hans-Peter [Person:9684953] King, Brett [Person:9684955] Matsuda, Zene [Summation:9684956] Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid th... [Person:9684957] Damsky, William [LiteratureReference:9684958] The use of Janus kinase inhibitors in the time of SARS-CoV-2 [Person:9684959] Inoue, Jun-Ichiro [Summation:9684960] The Janus kinases (JAKs) are a family of intracellular tyros... |
| (modified) | [ChemicalDrug:9678745] siponimod [extracellular region] [ChemicalDrug:9678808] fingolimod [extracellular region] [Reaction:9678854] S1PR1 binds S1PR1 agonists [Homo sapiens] [Reaction:9678882] PRSS1(19-247) binds PRSS1 inhibitors [Homo sapiens] [Reaction:9678935] IFNAR2:JAK1:STAT2 binds JAK1,2 inhibitors [Homo sapiens] [Pathway:9679191] Potential therapeutics for SARS [Homo sapiens] [Reaction:9683467] CQ, HCQ are protonated to CQ2+, HCQ2+ [Homo sapiens] [Reaction:9683478] CQ, HCQ diffuses from cytosol to endocytic vesicle lumen [Homo sapiens] [Summation:9683487] Chloroquine (CQ) and hydroxychloroquine (HCQ) are diprotic w... |
|
[Change default viewing format]
|
No pathways have been reviewed or authored by Jassal, Bijay, 2020-04-22 (9684954)